Scientific Considerations in Submitting Synthetic Peptide Drug Products as ANDAs Referencing Peptide Drug products of rDNA origin
Author/sZhang, Deyi
Date:11/15/2016
Meeting Name:USP Workshop on Synthetic Therapeutic Peptide – Regulations, Standards and Quality
State:MD
City:Rockville